INSIGHTS ON DRUG DEVELOPMENT

• 384-Well Microplate Time Resolved Fluorescence (TRF) Immunoassay

  Examine how innovative sandwich ELISAs in a 384-well format can be utilized with a sensitive reader for high-throughput screening to quantify Human IgG and IFN gamma.

• Organ-Chips: A Promising Model For Human Emulation

  Organ-Chips offer more accurate assessments of safety and efficacy readouts compared to other cell and animal models used by academia, government, and pharmaceutical entities to study drug toxicity.

• Leveraging Optimized Transient Expression For Material Generation And Early Stage Insight

  By using an optimized transient transfection platform, drug developers can accelerate their characterization and early development activities, facilitating continuity for a drug's scale-up.

• Breaking The Chains Of Conventional Drug Research Models

  Gain insight into the limitations of conventional research models, how Organ-Chips are helping researchers bridge the translation gap and overcome pervasive barriers in drug development, and more.

• Versatile Lipid Nanoparticle Platform For Efficient Gene Editing

  6/3/2025

  Lipid nanoparticles enable efficient gene editing in hard-to-transfect cells like T-cells and blood stem cells, which offers scalable, clinically relevant methods for developing advanced therapies for cancer and rare diseases.

• Revolutionizing Drug Discovery: The Rise Of Fashionable Models

  6/6/2024

  As a result of advancements in research technology, "fashionable models" such as organoids and organs-on-chips (OoCs) have been developed. Explore organoid and OoC technologies in detail.

• Proximal Tubule Kidney-Chip For Modeling Human Physiology

  3/14/2024

  Discover how an Organ-Chip can be used to create a comprehensive recapitulation of the proximal tubule, addressing the need for more human-relevant preclinical models in the pharmaceutical industry.

• Reduce Costly Scale-Up Problems

  4/11/2024

  Scaling a new drug formulation from development to manufacturing often presents challenges, but there are ways to minimize deviations and streamline your transition.

• A Novel Patient-Derived Colorectal Cancer Organoid Platform

  4/22/2025

  Patient-derived organoids are revolutionizing drug discovery by mimicking tumors and predicting therapeutic efficacy. Discover a scalable bioprocess that enhances reproducibility and cost-effectiveness to pave the way for broader adoption.